NIH released several important notices over the last few weeks. Below is a brief summary of each item. To read each complete notice (NOT): https://grants.nih.gov/policy-and-compliance/notice-of-policy-changes Supporting Fairness and Originality in NIH Research Applications. NIH is evaluating applications closely for substantial use of AI. NIH also will now only accept a maximum of 6 applications per […]| Bouvier Grant Group
You have an idea for a full-scale clinical trial that you would like to eventually fund with an R01. How do you go from concept to R01 funding for the full-scale trial? NIH has several funding mechanisms that can help you lay the groundwork for a future R01-funded trial. Here, we outline some of the […] The post Spotlight on R34, R21, R61/R33: NIH Mechanisms to Help You Prepare for a Future R01-funded clinical trial appeared first on Bouvier Grant Group.| Bouvier Grant Group
The NIH DP2 activity code supports highly innovative research by new investigators in all areas of biomedical and behavioral research. NIH currently has three active DP2 Notices of Funding Opportunity (NOFO). We’ve summarized them for you below. It is always a good idea to speak with the program officers of these NOFOs to determine whether […] The post A Comparison of 3 NIH New Innovator Awards (DP2): Office of the Director High-Risk, High-Reward; NIDA; and NIAID appeared first on Bouvier...| Bouvier Grant Group
I have received a lot of requests lately for help writing an NIH rebuttal, so it seems like a good time to talk about what they are and how to write one. Rebuttals seem to go in and out of vogue at NIH, and for whatever reason right now, many program officers (POs) are requesting […]| Bouvier Grant Group
The NIH Director’s New Innovator Award (activity code DP2) supports Early-Stage Investigators (ESIs) who are pursuing highly innovative research that has the potential to have a major impact on areas relevant to NIH mission. Applications can be basic, translational, or clinical in nature. The Notice of Funding Opportunity (RFA-RM-25-002) allows for clinical trials, though it […] The post Spotlight on the NIH Director’s New Innovator Award – DP2 appeared first on Bouvier Grant Group.| Bouvier Grant Group
Health science researchers in the U.S. naturally gravitate toward National Institutes of Health (NIH) grants to fund their work, but other sources are available. And with the looming threat of NIH budget cuts, interest in alternatives may be on the rise. One such (perhaps surprising?) resource: the U.S. Department of Defense (DOD). You’re familiar with […]| Bouvier Grant Group
Our company mission is to mentor NIH applicants and help give their biomedical research the best chance of funding success.| Bouvier Grant Group
Health science researchers in the U.S. naturally gravitate toward National Institutes of Health (NIH) grants to fund their work, but other sources are available. And with the looming threat of NIH budget cuts, interest in alternatives may be on the rise. One such (perhaps surprising?) resource: the U.S. Department of Defense (DOD). You’re familiar with […]| Bouvier Grant Group
I receive a lot of questions from worried applicants and clients about how to navigate the volatile NIH funding landscape.| Bouvier Grant Group
Dr. Francis Collins recently announced his retirement from the federal government after a long and distinguished career in service. Many people have already written about his illustrious career. I had the great fortune to work for Dr. Collins, so I thought I would share some of my memories of him. While I was working as […] The post Dr. Bouvier’s Personal Memories of Dr. Francis Collins, retired NIH Director. appeared first on Bouvier Grant Group.| Bouvier Grant Group
For over 40 years, the U.S. federal government has provided non-dilutive funding for small businesses across the country through the Small Business Innovation Research (SBIR) programs. Ten years after the initiation of SBIR, a companion effort was launched to support small businesses partnerships with research institutions, the Small Business Technology Transfer (STTR) programs. SBIR and/or […] The post SBIR/STTR still going strong, but will it be renewed? appeared first on Bouvier Gran...| Bouvier Grant Group
As research funding becomes increasingly competitive, organizations seek resources to give their researchers an advantage.| Bouvier Grant Group
In February 2024, we brought you a first installment regarding AI and grantwriting courtesy of colleague and guest writer Dr. Agnella Izzo Matic. As you may imagine, the topic of AI as a whole and, similarly, AI as it relates to grantwriting and scientific writing is evolving. For a bit of background into what AI is, […]| Bouvier Grant Group
Guest Post by Dr. Agnella Izzo Matic TL;DR – AI is a new tool that can (and should) be leveraged to speed up some specific parts of the writing process that can be automated – saving time and mental bandwidth for the parts of the process that need idea generation and critical analysis. AI won’t […]| Bouvier Grant Group